The effect of synbiotic supplementation on body composition and lipid profile in patients with NAFLD: A randomized, double blind, placebo-controlled clinical trial study

Iranian Red Crescent Medical Journal

Volumn 19, Issue 4, 2017, Pages

  Asgharian, Atefe ^a   Mohammadi, Vida ^b   Gholi, Zahra ^b   Esmaillzade, Ahmad ^c   Feizi, Awat ^d   Askari, Gholamreza ^b  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body composition; HDL cholesterol; LDL cholesterol; Lipid profile; Nonalcoholic fatty liver disease; Symbiotic; Total cholesterol

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FRUCTOSE OLIGOSACCHARIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROBIOTIC AGENT; SYNBIOTIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 85018386563     PISSN: 20741804     EISSN: 20741812     Source Type: Journal    
DOI: 10.5812/ircmj.42902     Document Type: Article

References (30)

1. Lam B, Younossi ZM. Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2010;3(2):121-37. doi: 10.1177/1756283X09359964. [PubMed: 21180596].
2. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology. 2002;35(2):367-72. doi: 10.1053/jhep.2002.30690. [PubMed: 11826410].
3. Jamali RJA. Non-alcoholic fatty liver disease. FEYZ. 2010;14(2):12.
4. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003;124(1):71-9. doi: 10.1053/gast.2003.50004. [PubMed: 12512031].
5. Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009;29(2):159-63. doi: 10.1111/j.1478-3231.2008.01790.x. [PubMed: 18492015].
6. Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A, et al. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol. 2008;14(18):2867-71. [PubMed: 18473412].
7. Iacono A, Raso GM, Canani RB, Calignano A, Meli R. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J Nutr Biochem. 2011;22(8):699-711. doi: 10.1016/j.jnutbio.2010.10.002. [PubMed: 21292470].
8. Bhathena J, Martoni C, Kulamarva A, Tomaro-Duchesneau C, Malhotra M, Paul A, et al. Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters. PLoS One. 2013;8(3):ee58394. doi: 10.1371/journal.pone.0058394. [PubMed: 23554890].
9. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804-10. doi: 10.1038/nature06244. [PubMed: 17943116].
10. Machado MV, Cortez-Pinto H. Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol. 2012;11(4):440-9. [PubMed: 22700625].
11. Ewaschuk J, Endersby R, Thiel D, Diaz H, Backer J, Ma M, et al. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology. 2007;46(3):841-50. doi: 10.1002/hep.21750. [PubMed: 17659579].
12. Gratz SW, Mykkanen H, El-Nezami HS. Probioticsandgut health: a special focus on liver diseases. World J Gastroenterol. 2010;16(4):403-10. [PubMed: 20101763].
13. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci. 2007;52(11):3259-65. doi: 10.1007/s10620-006-9687-y. [PubMed: 17393330].
14. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9 Suppl):S498-504. [PubMed: 10993420].
15. Drenick EJ, Fisler J, Johnson D. Hepatic steatosis after intestinal bypass-prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology. 1982;82(3):535-48. [PubMed: 6797866].
16. Nazim M, Stamp G, Hodgson HJ. Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth. Hepatogastroenterology. 1989;36(5):349-51. [PubMed: 2516007].
17. Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis. 2015;47(3):181-90. doi: 10.1016/j.dld.2014.09.020. [PubMed: 25739820].
18. Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee KE, et al. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in dietinduced obese mice. Biochim Biophys Acta. 2006;1761(7):736-44. doi: 10.1016/j.bbalip.2006.05.007. [PubMed: 16807088].
19. Sato M, Uzu K, Yoshida T, Hamad EM, Kawakami H, Matsuyama H, et al. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr. 2008;99(5):1013-7. doi: 10.1017/S0007114507839006. [PubMed: 17977471].
20. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070-5. doi: 10.1073/pnas.0504978102. [PubMed: 16033867].
21. Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol. 2014;20(43):16079-94. doi: 10.3748/wjg.v20.i43.16079. [PubMed: 25473159].
22. An HM, Park SY, Lee DK, Kim JR, Cha MK, Lee SW, et al. Antiobesity and lipid-lowering effects of Bifidobacteriumspp. in high fat diet-induced obese rats. Lipids Health Dis. 2011;10:116. doi: 10.1186/1476-511X-10-116. [PubMed: 21745411].
23. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci. 2011;94(7):3288-94. doi: 10.3168/jds.2010-4128. [PubMed: 21700013].
24. Ibnou-Zekri N, Blum S, Schiffrin EJ, von derWeid T. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun. 2003;71(1):428-36. [PubMed: 12496193].
25. Pereira DI, Gibson GR. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol. 2002;37(4):259-81. doi: 10.1080/10409230290771519. [PubMed: 12236466].
26. Hosono A. Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats. J Dairy Sci. 2000;83(8):1705-11. doi: 10.3168/jds.S0022-0302(00)75039-9. [PubMed: 10984145].
27. Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol. 2013;19(40):6911-8. doi: 10.3748/wjg.v19.i40.6911. [PubMed: 24187469].
28. Ghasemi HA, Shivazad M, Mirzapour Rezaei SS, Karimi Torshizi MA. Effect of synbiotic supplementation and dietary fat sources on broiler performance, serum lipids, muscle fatty acid profile and meat quality. Br Poult Sci. 2016;57(1):71-83. doi: 10.1080/00071668.2015.1098766. [PubMed: 26654967].
29. Wong VW, Won GL, Chim AM, Chu WC, Yeung DK, Li KC, et al. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-ofconcept study. Ann Hepatol. 2013;12(2):256-62. [PubMed: 23396737].
30. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. 1995;108(4):975-82. [PubMed: 7698613].